Skip to content
★ Sign in to follow
Total declarations
2
Company
1
▲ Purchases (2 ops.)
€374k
▼ Sales (0 ops.)
—

Latest filing published 26 Sept 2017 for AstraZeneca PLC.

Insider track record

Disclosed buys
2
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
2

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Sean Bohen: trading record in brief

Sean Bohen appears in our data through filings on AstraZeneca PLC shares, published by Finansinspektionen. The record holds 2 filings, for trades running from 26 September 2016 to 25 September 2017.

Purchases make up the whole of the open-market record (2 purchases, €374k). The totals exclude 1 filing filed without an amount. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Since January 2017: 1 purchase and no sales on the market.

The newest entry dates from 26 September 2017: an open-market purchase, in AstraZeneca PLC. Source: insider filings from Finansinspektionen. Past trades are no guide to future returns.

Companies and markets linked to Sean Bohen

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations2 total
  • ▲
    Person discharging managerial responsibilitiesExecutivesAstraZeneca PLC
    0FCA-NSM
    12,385 sharesOutside a trading venueFCA-NSM:LSE20170926120001_13375871_20200330131541072_18596
    Canonical exit: 24 Dec 2017 (T+90)
  • ▲
    Executive Vice-President, Global Medicines Development and Chief Medical OfficerExecutivesAstraZeneca PLC
    420,718 USD19FCA-NSM
    12,385 shares@ US$33.97100.0% of flowNew YorkFCA-NSM:LSE20160926160001_012979092_20200330143620024_19415
    Canonical exit: 25 Dec 2016 (T+90)

2 of 2 declarations